Published in Cancer Weekly, March 9th, 2010
"For gene-expression analysis quantitative TaqMan® low-density arrays were applied. Expression levels in pretreatment biopsies of 41 patients (cT2-4, Nx, MO) were compared with the degree of histopathologic regression in resected specimens applying univariate, multivariate and artificial neuronal network analyses. Dihydropyrimidine dehydrogenase was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly